Get started
AlenCiken

100 Percent Survival in Critical COVID-19 Patients

Capricor Therapeutics, Inc. (NASDAQ:CAPR)  
AlenCiken  
NASDAQ:CAPR   Capricor Therapeutics, Inc.
Fundamental Analysis Trend Analysis Chart Patterns
7
0
fundamental trendanalysis chartpattern
New Capricor Data Reports 100 Percent Survival in Critical COVID-19 patients who were treated with Capricor’s lead asset, off-the-shelf (“allogeneic”) cardiac cell therapy CAP-1002, at Cedars-Sinai Medical Center as part of six compassionate care cases.


www.irdirect.net/prv...r/release/id/4306152
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.